RecruitingPhase 1Phase 2NCT04845217
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
Efficacy of Peppermint Oil in a Randomized, Single-Blind, Placebo Controlled Trial in Women With Interstitial Cystitis/Bladder Pain Syndrome
Sponsor
University of Louisville
Enrollment
100 participants
Start Date
Sep 15, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years
Inclusion Criteria2
- Women ages 18-65 years old
- Diagnosed with IC/BPS for at least one month prior to study enrollment
Exclusion Criteria11
- Culture proven urinary tract infection within 1 month of randomization
- Gross hematuria
- Currently pregnant or breastfeeding
- Unable to speak and read English
- History of allergic reaction to peppermint, coconut or enteric coating
- History of malabsorption syndrome
- History of gastroparesis
- History of gastric bypass surgery
- History of gastrointestinal, genitourinary or pelvic cancer in the last 5 years
- History of insulin dependent diabetes
- History of active urinary stone disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPeppermint oil
Enteric coated peppermint oil taken by mouth three times daily for 8 weeks.
DRUGCoconut Oil
Enteric coated coconut oil taken by mouth three times daily for 8 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04845217
Related Trials
Investigation of PEMF Therapy for Female Patients With IC/BPS
NCT051495731 location
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
NCT051276163 locations
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
NCT063948305 locations
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
NCT0573712114 locations
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
NCT062996831 location